maker of tirzepatide Eli Lilly launched a four-dose, single-patient use KwikPen device for its injectable obesity drug, (Zepbound). The device gives patients an additional, potentially more convenient option for taking the drug: They can maker of tirzepatide manufacturer of

Assumptions and limitations This is a population-average planning tool, not a personal prediction engine

doi:10.1146/annurev.immunol.14.1.397

The results After investigating bone health at people's critical areas in their hips, spines and forearms, researchers found that those who took just the liraglutide saw their bone mineral density drop compared to the exercise group, with a mean decrease of 0.013 grams of mineral per centimetre of bone at their hips and 0.016 grams per centimetre at their spine

This remains a hypothesis to be tested rather than an established conclusion

The precise mechanism of action might still be unknown, but research into the effects DSIP has is both extensive and surprisingly broad

Since then, the maximum dose for diabetes treatment has increased to 2 mg per week, which is comparable to the 2.4 mg dose